Pathology of the dentate gyrus in neurodegenerative disease

Richard A. Armstrong

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

Abstract

The dentate gyrus (DG) is an important part of the hippocampal formation and is believed to be involved in a variety of brain functions including episodic and spatial memory and the exploration of novel environments. In several neurodegenerative disorders, significant pathology occurs in the DG which may be involved in the development of clinical dementia. Based on the abundance of pathological change, neurodegenerative disorders can be divided into three groups: (1) those in which high densities of neuronal cytoplasmic inclusions (NCI) are present in DG granule cells, e.g., Pick’s disease (PiD), frontotemporal lobar degeneration with TDP-43-immunoreactive inclusions (FTLD-TDP), and neuronal intermediate filament inclusion disease (NIFID), (2) those in which aggregated protein deposits are distributed throughout the hippocampal formation including the molecular layer of the DG, e.g., Alzheimer’s disease (AD), Down’s syndrome (DS), and variant Creutzfeldt-Jakob disease (vCJD), and (3) those in which in there is significantly less pathology in the DG, e.g., Parkinson’s disease dementia (PD-Dem), dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and sporadic CJD (sCJD). Hence, DG pathology varies significantly among disorders which could contribute to differences in clinical dementia. Pathological differences among disorders could reflect either differential vulnerability of the DG to specific molecular pathologies or variation in the degree of spread of pathological proteins into the hippocampal formation from adjacent regions.
Original languageEnglish
Title of host publicationDentate gyrus
Subtitle of host publicationstructure, role in disease, and potential health implications
EditorsZachery Lowes
Place of PublicationHauppage, NY (US)
PublisherNova science
Pages47-68
Number of pages22
ISBN (Electronic)978-1-63463-406-9
ISBN (Print)978-1-63463-371-0
Publication statusPublished - 2015

Publication series

NameNeuroscience Research Progress
PublisherNova Science

Fingerprint

dementia
pathology
Disease
inclusion
Down Syndrome
brain
vulnerability
Group

Keywords

  • dentate gyrus
  • hippocampal formation
  • perforant path
  • spatial memory
  • neurodegenerative diseases

Cite this

Armstrong, R. A. (2015). Pathology of the dentate gyrus in neurodegenerative disease. In Z. Lowes (Ed.), Dentate gyrus: structure, role in disease, and potential health implications (pp. 47-68). (Neuroscience Research Progress). Hauppage, NY (US): Nova science.
Armstrong, Richard A. / Pathology of the dentate gyrus in neurodegenerative disease. Dentate gyrus: structure, role in disease, and potential health implications. editor / Zachery Lowes. Hauppage, NY (US) : Nova science, 2015. pp. 47-68 (Neuroscience Research Progress).
@inbook{165533143ca34918b9a98ce30037d58a,
title = "Pathology of the dentate gyrus in neurodegenerative disease",
abstract = "The dentate gyrus (DG) is an important part of the hippocampal formation and is believed to be involved in a variety of brain functions including episodic and spatial memory and the exploration of novel environments. In several neurodegenerative disorders, significant pathology occurs in the DG which may be involved in the development of clinical dementia. Based on the abundance of pathological change, neurodegenerative disorders can be divided into three groups: (1) those in which high densities of neuronal cytoplasmic inclusions (NCI) are present in DG granule cells, e.g., Pick’s disease (PiD), frontotemporal lobar degeneration with TDP-43-immunoreactive inclusions (FTLD-TDP), and neuronal intermediate filament inclusion disease (NIFID), (2) those in which aggregated protein deposits are distributed throughout the hippocampal formation including the molecular layer of the DG, e.g., Alzheimer’s disease (AD), Down’s syndrome (DS), and variant Creutzfeldt-Jakob disease (vCJD), and (3) those in which in there is significantly less pathology in the DG, e.g., Parkinson’s disease dementia (PD-Dem), dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and sporadic CJD (sCJD). Hence, DG pathology varies significantly among disorders which could contribute to differences in clinical dementia. Pathological differences among disorders could reflect either differential vulnerability of the DG to specific molecular pathologies or variation in the degree of spread of pathological proteins into the hippocampal formation from adjacent regions.",
keywords = "dentate gyrus, hippocampal formation, perforant path, spatial memory, neurodegenerative diseases",
author = "Armstrong, {Richard A.}",
year = "2015",
language = "English",
isbn = "978-1-63463-371-0",
series = "Neuroscience Research Progress",
publisher = "Nova science",
pages = "47--68",
editor = "Zachery Lowes",
booktitle = "Dentate gyrus",

}

Armstrong, RA 2015, Pathology of the dentate gyrus in neurodegenerative disease. in Z Lowes (ed.), Dentate gyrus: structure, role in disease, and potential health implications. Neuroscience Research Progress, Nova science, Hauppage, NY (US), pp. 47-68.

Pathology of the dentate gyrus in neurodegenerative disease. / Armstrong, Richard A.

Dentate gyrus: structure, role in disease, and potential health implications. ed. / Zachery Lowes. Hauppage, NY (US) : Nova science, 2015. p. 47-68 (Neuroscience Research Progress).

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

TY - CHAP

T1 - Pathology of the dentate gyrus in neurodegenerative disease

AU - Armstrong, Richard A.

PY - 2015

Y1 - 2015

N2 - The dentate gyrus (DG) is an important part of the hippocampal formation and is believed to be involved in a variety of brain functions including episodic and spatial memory and the exploration of novel environments. In several neurodegenerative disorders, significant pathology occurs in the DG which may be involved in the development of clinical dementia. Based on the abundance of pathological change, neurodegenerative disorders can be divided into three groups: (1) those in which high densities of neuronal cytoplasmic inclusions (NCI) are present in DG granule cells, e.g., Pick’s disease (PiD), frontotemporal lobar degeneration with TDP-43-immunoreactive inclusions (FTLD-TDP), and neuronal intermediate filament inclusion disease (NIFID), (2) those in which aggregated protein deposits are distributed throughout the hippocampal formation including the molecular layer of the DG, e.g., Alzheimer’s disease (AD), Down’s syndrome (DS), and variant Creutzfeldt-Jakob disease (vCJD), and (3) those in which in there is significantly less pathology in the DG, e.g., Parkinson’s disease dementia (PD-Dem), dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and sporadic CJD (sCJD). Hence, DG pathology varies significantly among disorders which could contribute to differences in clinical dementia. Pathological differences among disorders could reflect either differential vulnerability of the DG to specific molecular pathologies or variation in the degree of spread of pathological proteins into the hippocampal formation from adjacent regions.

AB - The dentate gyrus (DG) is an important part of the hippocampal formation and is believed to be involved in a variety of brain functions including episodic and spatial memory and the exploration of novel environments. In several neurodegenerative disorders, significant pathology occurs in the DG which may be involved in the development of clinical dementia. Based on the abundance of pathological change, neurodegenerative disorders can be divided into three groups: (1) those in which high densities of neuronal cytoplasmic inclusions (NCI) are present in DG granule cells, e.g., Pick’s disease (PiD), frontotemporal lobar degeneration with TDP-43-immunoreactive inclusions (FTLD-TDP), and neuronal intermediate filament inclusion disease (NIFID), (2) those in which aggregated protein deposits are distributed throughout the hippocampal formation including the molecular layer of the DG, e.g., Alzheimer’s disease (AD), Down’s syndrome (DS), and variant Creutzfeldt-Jakob disease (vCJD), and (3) those in which in there is significantly less pathology in the DG, e.g., Parkinson’s disease dementia (PD-Dem), dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and sporadic CJD (sCJD). Hence, DG pathology varies significantly among disorders which could contribute to differences in clinical dementia. Pathological differences among disorders could reflect either differential vulnerability of the DG to specific molecular pathologies or variation in the degree of spread of pathological proteins into the hippocampal formation from adjacent regions.

KW - dentate gyrus

KW - hippocampal formation

KW - perforant path

KW - spatial memory

KW - neurodegenerative diseases

UR - http://www.scopus.com/inward/record.url?scp=84955684037&partnerID=8YFLogxK

UR - https://www.novapublishers.com/catalog/product_info.php?products_id=52199&osCsid=7dfdad7e4ac5f02ee87b648c1b8363cd

M3 - Chapter (peer-reviewed)

SN - 978-1-63463-371-0

T3 - Neuroscience Research Progress

SP - 47

EP - 68

BT - Dentate gyrus

A2 - Lowes, Zachery

PB - Nova science

CY - Hauppage, NY (US)

ER -

Armstrong RA. Pathology of the dentate gyrus in neurodegenerative disease. In Lowes Z, editor, Dentate gyrus: structure, role in disease, and potential health implications. Hauppage, NY (US): Nova science. 2015. p. 47-68. (Neuroscience Research Progress).